This Fortnight in Medicine XXV

Sensible Medicine

This Fortnight in Medicine XXV

0:00

-30:20

This Fortnight in Medicine XXV

Paxlovid and a Polypill

Adam Cifu, MD, John Mandrola, and Andrew J Foy

May 06, 2026

Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients

Real-World Effectiveness of Nirmatrelvir–Ritonavir Against Severe Outcomes of COVID-19 in Taiwan: A Nationwide Population-Based Cohort Study

Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage

Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study

Discussion about this episode

Ready for more?

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts